miR-21 alleviates secondary blood–brain barrier damage after traumatic brain injury in rats

[1]  Jian-ning Zhang,et al.  miR-21 improves the neurological outcome after traumatic brain injury in rats , 2014, Scientific Reports.

[2]  Yunfei Wei,et al.  ApoE-Deficient Promotes Blood–Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9 , 2014, Journal of Molecular Neuroscience.

[3]  J. Sheng,et al.  Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. , 2014, Biomaterials.

[4]  Jing-fei Dong,et al.  Stress-dose hydrocortisone reduces critical illness-related corticosteroid insufficiency associated with severe traumatic brain injury in rats , 2013, Critical Care.

[5]  Lei Han,et al.  AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. , 2013, Cancer research.

[6]  A. Mustafa,et al.  Pathophysiology of traumatic brain injury. , 2013, Neurosciences.

[7]  N. Chandra,et al.  Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. , 2013, Free radical biology & medicine.

[8]  Margaret A. Parsley,et al.  Inflammatory consequences in a rodent model of mild traumatic brain injury. , 2013, Journal of neurotrauma.

[9]  F. Tchantchou,et al.  Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. , 2013, Journal of neurotrauma.

[10]  J. Rafols,et al.  Reduction of brain edema and expression of aquaporins with acute ethanol treatment after traumatic brain injury. , 2013, Journal of neurosurgery.

[11]  Shanthi Ameratunga,et al.  Incidence of traumatic brain injury in New Zealand: a population-based study , 2013, The Lancet Neurology.

[12]  M. Chopp,et al.  Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome , 2012, Neuroscience.

[13]  K. Blennow,et al.  The Neuropathology and Neurobiology of Traumatic Brain Injury , 2012, Neuron.

[14]  H. Shalev,et al.  Blood–brain barrier dysfunction in brain diseases: Clinical experience , 2012, Epilepsia.

[15]  Jian-ning Zhang,et al.  SDF-1α induces angiogenesis after traumatic brain injury , 2012, Brain Research.

[16]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[17]  A. Peitzman,et al.  Effect of the modified Glasgow Coma Scale score criteria for mild traumatic brain injury on mortality prediction: comparing classic and modified Glasgow Coma Scale score model scores of 13. , 2011, The Journal of trauma.

[18]  G. Rosenberg,et al.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.

[19]  E. Yan,et al.  Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury , 2011, Journal of Neuroinflammation.

[20]  Didier Y. R. Stainier,et al.  Molecular control of endothelial cell behaviour during blood vessel morphogenesis , 2011, Nature Reviews Molecular Cell Biology.

[21]  C. Luo,et al.  Immediate splenectomy decreases mortality and improves cognitive function of rats after severe traumatic brain injury. , 2011, The Journal of trauma.

[22]  P. Dash,et al.  Altered expression of miRNA‐21 and its targets in the hippocampus after traumatic brain injury , 2011, Journal of neuroscience research.

[23]  D. Ferriero,et al.  Role of vasodilator stimulated phosphoprotein in VEGF induced blood–brain barrier permeability in endothelial cell monolayers , 2010, International Journal of Developmental Neuroscience.

[24]  N. Mochizuki,et al.  Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. , 2010, Histology and histopathology.

[25]  Mei Mei,et al.  Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status , 2010, Laboratory Investigation.

[26]  D. Senger.  Vascular Endothelial Growth Factor: Much More than an Angiogenesis Factor , 2010, Molecular biology of the cell.

[27]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[28]  B. Aggarwal,et al.  Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer. , 2009, Advances in experimental medicine and biology.

[29]  Jian-ning Zhang,et al.  Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury , 2009, Brain Research.

[30]  P. Dash,et al.  Traumatic brain injury alters expression of hippocampal microRNAs: Potential regulators of multiple pathophysiological processes , 2009, Journal of neuroscience research.

[31]  Gavin Thurston,et al.  Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.

[32]  M. Chopp,et al.  Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke , 2008, Journal of cellular and molecular medicine.

[33]  Anthony Marmarou,et al.  A review of progress in understanding the pathophysiology and treatment of brain edema. , 2007, Neurosurgical focus.

[34]  M. Chopp,et al.  Angiopoietin1/TIE2 and VEGF/FLK1 Induced by MSC Treatment Amplifies Angiogenesis and Vascular Stabilization after Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  M. Chopp,et al.  Nitric oxide regulates Angiopoietin1/Tie2 expression after stroke , 2006, Neuroscience Letters.

[36]  Nikolaus Plesnila,et al.  Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. , 2006, Journal of neurotrauma.

[37]  W. Young,et al.  Effects of angiopoietin-1 on vascular endothelial growth factor-induced angiogenesis in the mouse brain. , 2006, Acta neurochirurgica. Supplement.

[38]  Peter Sandercock,et al.  Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months , 2005, The Lancet.

[39]  M. Chopp,et al.  Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in Rats , 2001, Stroke.

[40]  R. Dempsey,et al.  The biphasic opening of the blood–brain barrier in the cortex and hippocampus after traumatic brain injury in rats , 1997, Neuroscience Letters.